TC
GDRX icon

Truvestments Capital’s GoodRx Holdings GDRX Stock Holding History

Truvestments Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-194
Closed -$904 – 796
2022
Q4 		$904 Sell
194
-888
-82% -$4.38K ﹤0.01% 831
2022
Q3 		$5K Buy
1,082
+260
+32% +$1.64K ﹤0.01% 468
2022
Q2 		$5K Buy
+822
New +$9.15K ﹤0.01% 476

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Truvestments Capital's GDRX Position: Q1 2023 in Review

Truvestments Capital sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 194 shares — an estimated $904 sold.

Truvestments Capital first reported a position in GDRX in Q2 2022 and held it in 3 quarters. The position peaked at $5K in Q3 2022. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • Truvestments Capital reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
  • Truvestments Capital sold 194 GoodRx Holdings shares in Q1 2023, an estimated $904.
  • Truvestments Capital first reported a position in GoodRx Holdings in Q2 2022 and held it in 3 quarters.
  • Truvestments Capital's GoodRx Holdings position peaked at $5K in Q3 2022.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.